{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:08:49Z","timestamp":1791094129392,"version":"4.1.0"},"reference-count":39,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2010,7,30]],"date-time":"2010-07-30T00:00:00Z","timestamp":1280448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Science"],"published-print":{"date-parts":[[2010,11]]},"abstract":"<jats:p>Murine studies have shown that immunological targeting of fibroblast activation protein (FAP) can elicit protective immunity in the absence of significant pathology. Fibroblast activation protein is a product overexpressed by tumor\u2010associated fibroblasts (TAF) and is the predominant component of the stoma in most types of cancer. Tumor\u2010associated fibroblasts differ from normal adult tissue fibroblasts, and instead resemble transient fetal and wound healing\u2010associated fibroblasts. Tumor\u2010associated fibroblasts are critical regulators of tumorigenesis, but differ from tumor cells by being more genetically stable. Therefore, in comparison to tumor cells, TAF may represent more viable therapeutic targets for cancer immunotherapy. To specifically target TAF, we constructed a DNA vaccine directed against FAP. This vaccine significantly suppressed primary tumor and pulmonary metastases primarily through CD8<jats:sup>+<\/jats:sup> T\u2010cell\u2010mediated killing in tumor\u2010bearing mice. Most importantly, tumor\u2010bearing mice vaccinated against FAP exhibited a 1.5\u2010fold increase in lifespan and no significant pathology. These results suggest that FAP, a product preferentially expressed by TAF, could function as an effective tumor rejection antigen. (<jats:italic>Cancer Sci<\/jats:italic> 2010; 101: 2325\u20132332)<\/jats:p>","DOI":"10.1111\/j.1349-7006.2010.01695.x","type":"journal-article","created":{"date-parts":[[2010,8,20]],"date-time":"2010-08-20T12:10:05Z","timestamp":1282306205000},"page":"2325-2332","source":"Crossref","is-referenced-by-count":148,"title":["Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model"],"prefix":"10.1111","volume":"101","author":[{"given":"Yuan","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun\u2010Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian\u2010Tai","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi\u2010Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li\u2010Na","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua\u2010Shan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya\u2010Ou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu\u2010Quan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,7,30]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(08)60911-6"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1200917"},{"key":"e_1_2_7_4_2","first-page":"737","article-title":"HLA class I antigen and transporter associated with antigen processing (TAPI and TAP2) down\u2010regulation in high\u2010grade primary breast carcinoma lesions","volume":"58","author":"Vitale M","year":"1998","journal-title":"Cancer Res"},{"key":"e_1_2_7_5_2","first-page":"5412","article-title":"Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis","volume":"59","author":"Shaheen RM","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(02)00241-6"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2805"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI26532"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/35077241"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.10142"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1067431"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.175.1.139"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20030849"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1090922"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.11.1549"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64742-6"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1096-1096"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.64.3.275"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0215234"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.51.36505"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.18.7235"},{"key":"e_1_2_7_22_2","first-page":"4767","article-title":"Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model","volume":"62","author":"Cheng JD","year":"2002","journal-title":"Cancer Res"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-1746"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-04-0269"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19970502)71:3<383::AID-IJC14>3.0.CO;2-H"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0925-4439(97)00032-X"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.12.5657"},{"key":"e_1_2_7_28_2","first-page":"3327","article-title":"Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin","volume":"53","author":"Rettig WJ","year":"1993","journal-title":"Cancer Res"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-0699"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0797-647"},{"key":"e_1_2_7_31_2","first-page":"1104","article-title":"Induction of autologous tumor killing by heat treatment of fresh human tumor cells: involvement of gamma delta T cells and heat shock protein 70","volume":"56","author":"Wei Y","year":"1996","journal-title":"Cancer Res"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-1587"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/80506"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.4.1553"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-12-3772"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1006\/scbi.2001.0417"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1159\/000069863"},{"key":"e_1_2_7_38_2","first-page":"1639","article-title":"A Phase I dose\u2010escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein positive cancer","volume":"9","author":"Scott AM","year":"2003","journal-title":"Clin Cancer Res"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.20.3.1089-1094.2000"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2001.01335.x"}],"container-title":["Cancer Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2010.01695.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2010.01695.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T04:20:32Z","timestamp":1697430032000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2010.01695.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,30]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["10.1111\/j.1349-7006.2010.01695.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2010.01695.x","archive":["Portico"],"relation":{},"ISSN":["1347-9032","1349-7006"],"issn-type":[{"value":"1347-9032","type":"print"},{"value":"1349-7006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,30]]}}}